Casirivimab Imdevimab

Product Description

It contains two monoclonal antibodies used together for the emergency treatment of mild to moderate covid-19 in adults and children aged 12 years and above and over 40 kg in weight. It is most effective if taken after an early laboratory diagnosis (within 7 to 10 days).The most common side effects of this monoclonal antibody therapy are injection site reactions, fever, flushing, shortness of breath, chest tightness, nausea, and vomiting. If you experience any of these side effects, let your doctor know immediately.Storage: Store in a refrigerator (2 - 8 Deg c). Do not freeze.                        Casirivimab + Imdevimab is sold internationally under the brand name REGEN-COV (also marketed as Ronapreve by Roche/Regeneron).